M. Silvia Sesana

Research technicians at University of Milano Bicocca, School of Medicine and Surgery, since 2001. She works in the CNLAB supporting the research activity focused on different pathologies of SNC, such as Alzheimer Disease;  nanoparticles formulation and functionalization and  nanoparticles cellular uptake. She also takes care of the management of the laboratory in terms of general organization, supplies, security. She is author of several articles published in the main international and national journals. She is inventor  of one family of Patents and partner of  a Spin-off Company (AmypoPharma, founded in 2015) of the University of Milano-Bicocca, whose mission is to bring nanoparticles for therapy of Amyloidosis to the clinical phase.